Jennifer

See full story
In early 2020, Jennifer began to experience numbness in her toes. Prior to her diagnosis, Jennifer experienced similar symptoms over the years, which her doctors first suggested “might just be a quirk of being Jennifer”. In April of 2020, Jennifer experienced numbness in her toes that spread to her ankles. Over the next couple of weeks, the numbness spread to her knees and Jennifer began to experience blurry vision, stiffness in her legs, and lightheadedness. Jennifer rationalized her symptoms as being the result of long workdays during COVID-19 stay-at-home orders. When the numbness reached her torso, Jennifer decided to go to her nurse practitioner who recommended a brain and spinal cord MRI. The doctor informed Jennifer that she had brain lesions and diagnosed her with relapsing-remitting Multiple sclerosis (MS) in 2020. She started immunosuppressant medication immediately.
For Jennifer, the stress of the diagnosis led to more symptoms, primarily unsteadiness that resulted in being unable to walk more than 20 feet without assistance. Jennifer’s doctor prescribed her some IV steroids, which reduced the symptoms. Jennifer sought information about MS on the internet from “authoritative medical websites” in order to understand what was happening to her body, treatment options, and what to expect. Jennifer’s research helped her tell people about her MS and challenge incorrect perceptions of MS. Social media, especially Instagram, allowed Jennifer to find people like her living with MS and made her “feel heard and supported.” Seeing herself represented among other young women and people her age living their lives with MS brought Jennifer a sense of comfort.
Jennifer finds MS to be lonely in that “nobody really has your symptoms, has your progression. It's really just you managing it the best you can and trying to find common ground with people in the best ways that we can, and just support each other through our own unique journeys.” Jennifer is very open with her MS story today. In addition to being deeply involved in fundraising and advocacy, she shares her story on social media and with her local MS chapter. In addition to her social media activism and advocacy, Jennifer has also started a Walk MS team for her corporation which received a lot of support from her co-workers.
Jennifer is now taking Ocrevus, a twice a year infusion, which gives Jennifer the “freedom to live 363 days a year not having a daily reminder” of MS. Now, Jennifer has permanent toe numbness, spasticity, tightness, and tingling in her legs especially if she is active, and a little black dot in her vision that appears when she is hot. Most of Jennifer’s symptoms are intermittent, except for the toe numbness that serves as “a permanent reminder” of her MS. She considers herself “very lucky and grateful to really be able to do everything” she was able to do before. Jennifer knew that MS would change her life, but she was not ready for how it changed her life. She has developed empathy and kindness, learned to say no, and how to listen to her body on this 13-month ongoing journey of self-learning and resiliency.
Clinical Trials Experience:
Jennifer became involved in clinical trials after looking on the MS website for updates on new medications for MS. Thinking that clinical trials were all medicine-related, Jennifer was pleasantly surprised that there were clinical trials for lifestyle changes. Jennifer felt empowered to get involved in these studies where she could “help science” while making changes that fit her lifestyle.
Jennifer’s first clinical trial experience was a study for newly diagnosed MS patients and aimed to help them cope with the mental uncertainty. For eight weeks, a social worker called Jennifer once a week to walk her though a cognitive behavior program “talking about the uncertainties, what parts of the uncertainty of MS were hard” for her and coping mechanisms. Jennifer learned that she dealt with uncertainty by exerting control. She spent “exorbitant amounts of time Googling and learning everything about MS” and the study taught her how to balance learning about MS and channeling her actions into other coping methods.
Being newly diagnosed, Jennifer identified with the uncertainty of MS and struggled with what it would mean for her. Jennifer decided to participate in the study because she felt she could “stick” to it and saw the potential benefits for her. Jennifer attributes much of her ability to process her MS to the study. As a younger person, she saw MS as a question mark for the rest of her life. The study helped Jennifer “learn to adapt” and rethink how she thought about her future. Now, she accepts the uncertainty, but she does not let it “cripple” her.
Jennifer has also participated in a study that examined whether intermittent fasting had an impact on the gut and how she felt. In this study, she was given an accelerometer that monitored her steps, when she was going up and down hills, and on stairs. Based on those results, she was given a projected calorie intake and asked to choose an eight-hour span in which she would eat. In addition to a body scan, the research team drew Jennifer’s blood twice. Because the eating window did not fit into her lifestyle or provide health benefits, Jennifer found it difficult to eat within the time span, but she remained honest with the research team about her difficulties and “failings” until study completion.
Jennifer is currently participating in a telehealth and yoga study that tests the benefits of stretching and yoga, as well as the benefits of telehealth. In this study, the research team allows participants to do yoga over telehealth and sends Jennifer a spreadsheet with the names of yoga moves for her to do twice a week that are tailored for people living with MS. For Jennifer, this study not only helped her spasticity, but made her feel that she was “truly helping” her community by showing the “power of telehealth for people that might not have the mobility and the easy transportation to get to facilities.”
Jennifer has had great experiences with the consent process as many of the research teams “go the extra mile” to let her know “all of the efforts and safeguards they’re going through to make sure” that her data are used in the way that they are supposed to be used and kept in the right hands. The consent process makes Jennifer “feel comfortable with the organization in the study” and tells her that they care about her and not just the data that she provides. Jennifer sees her participation in clinical trials as her way of paying it forward. Jennifer feels proud to be in clinical trials where she can help herself as well as future generations of people that have MS. She appreciates the people that participated in clinical trials before her, and she appreciates the people who will continue to do it after her.